Analogues of glucose-dependent insulinotropic polypeptide

Details for Australian Patent Application No. 2009280017 (hide)

Owner IPSEN Pharma S.A.S.

Inventors Dong, Zheng Xin

Agent Griffith Hack

Pub. Number AU-A-2009280017

PCT Pub. Number WO2010/016940

Priority 61/200,629 02.12.08 US; 61/188,191 07.08.08 US

Filing date 7 August 2009

Wipo publication date 11 February 2010

International Classifications

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

C07K 14/46 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/016940 Priority application(s): WO2010/016940

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009280021-Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal

2009280015-Glucose-dependent insulinotropic polypeptide analogues